RE:RE:RE:Recent Seeking Alpha article by “Canuck Investments”I posted about the SA article's statement on "bleeding cash", and nothing else. Your post goes in other directions. I'll bow out of the thread now and leave it to you and others who wish to discuss those other items.
.
LatticeInExile wrote: Concordia recognizes revenue on shipment, not sell through to customer which is flawed. What is the ratio of AR's to sales? Is this considered normal? How much of the quarters net revenues remained uncollected at the end of the quarter? After mandatory quarterly interest payments on the bridge, how much is left? When is the $21M due to the mysterious company they bought the four drugs from? When is the $12.5M paid in the arbitration settlement of the advisor that took them to court? The Cinven earn out is due Septemeber 1st ? Are they paying it all or are they taking the deferral on part of the paper? Kind of tight don't you think....
TickerTwit wrote: Quality control is weak on SeekingAlpha. “Canuck Investments” is a known quality problem there. My own crossings with him/her have been over articles on mining stocks where the author's lack of knowledge has been profoundly disturbing for its potential to mislead uneducated investors.
One posted comment on the CXR article:
"Right now Concordia is bleeding cash." [written by the author in the article - TT.]
[comment posted on SA in response to the article - TT.]
I am now looking at the Balance Sheet for 2016Q1. I observe that the cash position has risen from USD$155.4M to USD$178.5M over the quarter.
How could an increase in cash position be interpreted as "bleeding cash"?
.
TOMMY1 wrote: The author “Canuck Investments” ...